Australia Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: June 23, 2025 Report Code: GDME0742MDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “Australia Neurology Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Australia Neurology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Neuromodulation Devices, Interventional Neuroradiology, Neurological Diagnostic and Monitoring Equipment, Radiosurgery Systems Neurosurgical Products, Hydrocephalus Shunts and Minimally Invasive Neurosurgery

The Australia Neurology Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Neurology Devices Market.
• Global corporate-level profiles of key companies operating within the Australia Neurology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Australia Neurology Devices is segmented as follows – _x000D_

• Neuromodulation Devices_x000D_

• Interventional Neuroradiology_x000D_

• Neurological Diagnostic and Monitoring Equipment_x000D_

• Radiosurgery Systems_x000D_

• Neurosurgical Products_x000D_

• Hydrocephalus Shunts_x000D_

• Minimally Invasive Neurosurgery

Reasons to Buy

The Australia Neurology Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Medtronic Plc_x000D_
Boston Scientific Corp_x000D_
Stryker Corp_x000D_
Abbott Laboratories_x000D_
LivaNova PLC_x000D_
Nevro Corp_x000D_
Terumo Neuro_x000D_
Penumbra Inc_x000D_
Elekta AB_x000D_
Integra LifeSciences Corp_x000D_
Axonics Inc_x000D_
Natus Medical Inc_x000D_
Nihon Kohden Corp_x000D_
B. Braun Melsungen AG_x000D_
Cerenovus

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 8

2 Introduction 11

2.1 What Is This Report About? 11

2.2 Neurology Devices Market Segmentation 11

2.3 Definitions of Markets Covered in the Report 13

3 Neurology Devices Market, Australia 21

3.1 Neurology Devices Market, Australia, Revenue ($m), 2018-2033 21

3.2 Neurology Devices Market, Australia, Revenue Mix ($m), 2023 23

3.3 Neurology Devices Market, Australia, Category Contribution by Revenue ($m), 2023 24

3.4 Neurology Devices Market, Australia, Revenue ($m), 2018-2033 26

3.5 Neurology Devices Market, Australia, Volume (Units), 2018-2033 28

3.6 Neurology Devices Market, Australia, Volume (Units), 2018-2033 30

3.7 Neurology Devices Market, Australia, Company Share by Revenue ($m), 2023 33

4 Hydrocephalus Shunts Market, Australia 35

4.1 Hydrocephalus Shunts Market, Australia, Revenue Mix ($m), 2023 35

4.2 Hydrocephalus Shunts Market, Australia, Segment Contribution (%), 2023 36

4.3 Hydrocephalus Shunts Market, Australia, Revenue ($m), 2018-2033 38

4.3.1 Hydrocephalus Catheters Market, Australia, Revenue ($m), by Segment, 2018-2033 40

4.3.2 Hydrocephalus Valves Market, Australia, Revenue ($m), by Segment, 2018-2033 42

4.4 Hydrocephalus Shunts Market, Australia, Volume (Units), 2018-2033 44

4.4.1 Hydrocephalus Catheters Market, Australia, Volume (Units), by Segment, 2018-2033 46

4.4.2 Hydrocephalus Valves Market, Australia, Volume (Units), by Segment, 2018-2033 48

4.5 Hydrocephalus Shunts Market, Australia, Average Price ($) , 2018-2033 50

4.6 Hydrocephalus Shunts Market, Australia, Distribution Share by Revenue ($m), 2023 51

4.7 Hydrocephalus Shunts Market, Australia, Company Share by Revenue ($m), 2023 52

5 Interventional Neuroradiology Market, Australia 54

5.1 Interventional Neuroradiology Market, Australia, Revenue Mix ($m), 2023 54

5.2 Interventional Neuroradiology Market, Australia, Segment Contribution (%), 2023 55

5.3 Interventional Neuroradiology Market, Australia, Revenue ($m), 2018-2033 57

5.3.1 Neurovascular Accessory Devices Market, Australia, Revenue ($m), by Segment, 2018-2033 59

5.3.2 Neurovascular Coiling Assist Devices Market, Australia, Revenue ($m), by Segment, 2018-2033 61

5.3.3 Neurovascular Embolization Devices Market, Australia, Revenue ($m), by Segment, 2018-2033 63

5.3.4 Neurovascular Thrombectomy Devices Market, Australia, Revenue ($m), by Segment, 2018-2033 65

5.4 Interventional Neuroradiology Market, Australia, Volume (Units), 2018-2033 67

5.4.1 Neurovascular Accessory Devices Market, Australia, Volume (Units), by Segment, 2018-2033 69

5.4.2 Neurovascular Coiling Assist Devices Market, Australia, Volume (Units), by Segment, 2018-2033 71

5.4.3 Neurovascular Embolization Devices Market, Australia, Volume (Units), by Segment, 2018-2033 73

5.4.4 Neurovascular Thrombectomy Devices Market, Australia, Volume (Units), by Segment, 2018-2033 75

5.5 Interventional Neuroradiology Market, Australia, Average Price ($) , 2018-2033 77

5.6 Interventional Neuroradiology Market, Australia, Distribution Share by Revenue ($m), 2023 79

5.7 Interventional Neuroradiology Market, Australia, Company Share by Revenue ($m), 2023 80

6 Minimally Invasive Neurosurgery Market, Australia 82

6.1 Minimally Invasive Neurosurgery Market, Australia, Revenue Mix ($m), 2023 82

6.2 Minimally Invasive Neurosurgery Market, Australia, Segment Contribution (%), 2023 83

6.3 Minimally Invasive Neurosurgery Market, Australia, Revenue ($m), 2018-2033 85

6.3.1 Minimally Invasive Neurosurgical Devices Market, Australia, Revenue ($m), by Segment, 2018-2033 87

6.4 Minimally Invasive Neurosurgery Market, Australia, Volume (Units), 2018-2033 89

6.4.1 Minimally Invasive Neurosurgical Devices Market, Australia, Volume (Units), by Segment, 2018-2033 91

6.5 Minimally Invasive Neurosurgery Market, Australia, Average Price ($), 2018-2033 93

6.6 Minimally Invasive Neurosurgery Market, Australia, Distribution Share by Revenue ($m), 2023 94

6.7 Minimally Invasive Neurosurgery Market, Australia, Company Share by Revenue ($m), 2023 95

7 Neurological Diagnostic and Monitoring Equipment Market, Australia 97

7.1 Neurological Diagnostic and Monitoring Equipment Market, Australia, Revenue Mix ($m), 2023 97

7.2 Neurological Diagnostic and Monitoring Equipment Market, Australia, Segment Contribution (%), 2023 98

7.3 Neurological Diagnostic and Monitoring Equipment Market, Australia, Revenue ($m), 2018-2033 100

7.3.1 Electrical Activity Testing Market, Australia, Revenue ($m), by Segment, 2018-2033 102

7.3.2 ICP Monitoring Devices Market, Australia, Revenue ($m), by Segment, 2018-2033 104

7.4 Neurological Diagnostic and Monitoring Equipment Market, Australia, Volume (Units), 2018-2033 106

7.4.1 Electrical Activity Testing Market, Australia, Volume (Units), by Segment, 2018-2033 108

7.4.2 ICP Monitoring Devices Market, Australia, Volume (Units), by Segment, 2018-2033 110

7.5 Neurological Diagnostic and Monitoring Equipment Market, Australia, Average Price ($) , 2018-2033 112

7.6 Neurological Diagnostic and Monitoring Equipment Market, Australia, Distribution Share by Revenue ($m), 2023 113

7.7 Neurological Diagnostic and Monitoring Equipment Market, Australia, Company Share by Revenue ($m), 2023 114

8 Neuromodulation Devices Market, Australia 116

8.1 Neuromodulation Devices Market, Australia, Revenue Mix ($m), 2023 116

8.2 Neuromodulation Devices Market, Australia, Segment Contribution (%), 2023 117

8.3 Neuromodulation Devices Market, Australia, Revenue ($m), 2018-2033 119

8.3.1 Deep Brain Stimulators (DBS) Market, Australia, Revenue ($m), by Segment, 2018-2033 121

8.3.2 Gastric Electric Stimulators (GES) Market, Australia, Revenue ($m), by Segment, 2018-2033 123

8.3.3 Peripheral Nerve Stimulators (PNS) Market, Australia, Revenue ($m), by Segment, 2018-2033 125

8.3.4 Sacral Nerve Stimulators (SNS) Market, Australia, Revenue ($m), by Segment, 2018-2033 127

8.3.5 Spinal Cord Stimulators (SCS) Market, Australia, Revenue ($m), by Segment, 2018-2033 129

8.3.6 Vagus Nerve Stimulators (VNS) Market, Australia, Revenue ($m), by Segment, 2018-2033 131

8.4 Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033 133

8.4.1 Deep Brain Stimulators (DBS) Market, Australia, Volume (Units), by Segment, 2018-2033 135

8.4.2 Gastric Electric Stimulators (GES) Market, Australia, Volume (Units), by Segment, 2018-2033 137

8.4.3 Peripheral Nerve Stimulators (PNS) Market, Australia, Volume (Units), by Segment, 2018-2033 139

8.4.4 Sacral Nerve Stimulators (SNS) Market, Australia, Volume (Units), by Segment, 2018-2033 141

8.4.5 Spinal Cord Stimulators (SCS) Market, Australia, Volume (Units), by Segment, 2018-2033 143

8.4.6 Vagus Nerve Stimulators (VNS) Market, Australia, Volume (Units), by Segment, 2018-2033 145

8.5 Neuromodulation Devices Market, Australia, Average Price ($), 2018-2033 147

8.6 Neuromodulation Devices Market, Australia, Distribution Share by Revenue ($m), 2023 150

8.7 Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), 2023 151

9 Neurosurgical Products Market, Australia 153

9.1 Neurosurgical Products Market, Australia, Revenue Mix ($m), 2023 153

9.2 Neurosurgical Products Market, Australia, Segment Contribution (%), 2023 154

9.3 Neurosurgical Products Market, Australia, Revenue ($m), 2018-2033 156

9.3.1 Dura Substitutes Market, Australia, Revenue ($m), by Segment, 2018-2033 158

9.3.2 Neuroendoscopes Market, Australia, Revenue ($m), by Segment, 2018-2033 160

9.3.3 Neurosurgical Drills Market, Australia, Revenue ($m), by Segment, 2018-2033 162

9.4 Neurosurgical Products Market, Australia, Volume (Units), 2018-2033 164

9.4.1 Dura Substitutes Market, Australia, Volume (Units), by Segment, 2018-2033 166

9.4.2 Neuroendoscopes Market, Australia, Volume (Units), by Segment, 2018-2033 168

9.4.3 Neurosurgical Drills Market, Australia, Volume (Units), by Segment, 2018-2033 170

9.5 Neurosurgical Products Market, Australia, Average Price ($), 2018-2033 172

9.6 Neurosurgical Products Market, Australia, Distribution Share by Revenue ($m), 2023 174

9.7 Neurosurgical Products Market, Australia, Company Share by Revenue ($m), 2023 175

10 Radiosurgery Systems Market, Australia 177

10.1 Radiosurgery Systems Market, Australia, Revenue Mix ($m), 2023 177

10.2 Radiosurgery Systems Market, Australia, Segment Contribution (%), 2023 178

10.3 Radiosurgery Systems Market, Australia, Revenue ($m), 2018-2033 180

10.4 Radiosurgery Systems Market, Australia, Volume (Units), 2018-2033 182

10.5 Radiosurgery Systems Market, Australia, Average Price ($) , 2018-2033 184

10.6 Radiosurgery Systems Market, Australia, Distribution Share by Revenue ($m), 2023 185

10.7 Radiosurgery Systems Market, Australia, Company Share by Revenue ($m), 2023 186

11 Overview of Key Companies in Australia, Neurology Devices Market 188

11.1 Medtronic Plc 188

11.1.1 Company Overview 188

11.2 Boston Scientific Corp 188

11.2.1 Company Overview 188

11.3 Stryker Corp 188

11.3.1 Company Overview 188

11.4 Integra LifeSciences Corp 189

11.4.1 Company Overview 189

11.5 B. Braun Melsungen AG 189

11.5.1 Company Overview 189

11.6 Natus Medical Inc 189

11.6.1 Company Overview 189

11.7 KARL STORZ SE & Co KG 189

11.7.1 Company Overview 189

11.8 Terumo Neuro 189

11.8.1 Company Overview 189

11.9 Nevro Corp 190

11.9.1 Company Overview 190

11.10 Penumbra Inc 190

11.10.1 Company Overview 190

11.11 Abbott Laboratories 190

11.11.1 Company Overview 190

11.12 LivaNova Plc 190

11.12.1 Company Overview 190

11.13 Cerenovus 191

11.13.1 Company Overview 191

11.14 Elekta AB 191

11.14.1 Company Overview 191

12 Neurology Devices Market Pipeline Products 192

13 Financial Deals Landscape 203

13.1 Debt Offerings 203

13.1.1 Osteopore to Raise USD3.43 Million in First Tranche Private Placement of 4% Notes Due 2027 203

13.1.2 Osteopore to Raise USD3.43 Million in Second Tranche Private Placement of 4% Notes Due 2027 205

13.1.3 HitiQ to Raise USD1.07 Million in Private Placement of

12.5% Convertible Notes Due 2025 206

13.2 Equity Offerings 207

13.2.1 Emyria to Raise USD0.12 Million in Private Placement of Shares 207

13.2.2 Renerve Raises USD4.59 Million in Initial Public Offering (IPO) of Shares 208

13.2.3 Orthocell to Raise USD11.3 Million in Private Placement of Shares 209

13.2.4 DorsaVi to Raise USD0.36 Million in First Tranche Private Placement of Shares 210

13.2.5 DorsaVi to Raise USD0.36 Million in Second Tranche Private Placement of Shares 211

13.2.6 Compumedics Raises USD1.26 Million in Private Placement of Shares 212

13.2.7 Dorsavi Raises USD0.03 Million in Private Placement of Shares 214

13.3 Venture Financing 215

13.3.1 Neurode Raises USD3.5 Million in Pre-Seed Funding 215

14 Recent Developments 216

14.1 Corporate Communications 216

14.1.1 Apr 01, 2025: Neurotech Announces Resignation of Executive Director 216

14.1.2 Jan 14, 2025: R&D Tax Incentive Receipt and Repayment of RDTI Facility 216

14.1.3 Jan 13, 2025: Saluda Medical secures $100m for Evoke System commercialisation 216

14.1.4 Oct 03, 2024: HITIQ Appoints Earl Eddings as Executive Chairman 216

14.1.5 Aug 19, 2024: Fisher & Paykel Healthcare Appoints Mark Cross to Board 217

14.2 Financial Announcements 218

14.2.1 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 218

14.2.2 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance 218

14.3 Other Significant Developments 219

14.3.1 Nov 21, 2024: Dorsavi Commences Blockchain Integration Planning for Core Data Platform to Enhance Data Security and Compliance – Supplementary Information 219

14.3.2 Oct 17, 2024: Trading Update – USA and Europe 220

14.3.3 Jul 24, 2024: Memphasys Announces Sales, Product Development and Clinical Trial Update 220

14.4 Product News 222

14.4.1 Feb 04, 2025: Emyria Announces Promising 3 Month Follow-Up Clinical Results for PTSD Program 222

14.4.2 Jul 24, 2024: Memphasys Announces Sales, Product Development and Clinical Trial Update 223

14.4.3 Apr 30, 2024: Agilex Presents Advancing Patient Centric Neurological Biomarker Detection by Characterizing Ultrasensitive Assays to Alleviate CSF Sample Burden in San Antonio During WRIB 226

14.5 Strategy And Business Planning 226

14.5.1 Jun 12, 2024: ActiGraph and PKG Health Partner to Improve Outcomes in Neurology Trials 226

15 Appendix 228

15.1 Research Methodology 229

15.1.1 Coverage 229

15.1.2 Secondary Research 229

15.1.3 Primary Research 230

15.1.4 Market Modeling and Forecasting 231

15.1.5 Company Share Analysis 232

15.1.6 Distribution Share Analysis 232

15.1.7 Benchmarking 233

15.2 GlobalData Consulting 233

15.3 Contact Us 233

15.4 Disclaimer 234

Table

Table 1: Neurology Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 22

Table 2: Neurology Devices Market, Australia, Category Contribution by Revenue ($m), 2023 25

Table 3: Neurology Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 27

Table 4: Neurology Devices Market, Australia, Volume (Units), 2018-2033 29

Table 5: Neurology Devices Market, Australia, Volume (Units), 2018-2033 31

Table 6: Neurology Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2023 34

Table 7: Hydrocephalus Shunts Market, Australia, Segment Contribution (%), 2023 37

Table 8: Hydrocephalus Shunts Market, Australia, Revenue ($m), USD Constant, 2018-2033 39

Table 9: Hydrocephalus Catheters Market, Australia, Revenue ($m), USD Constant, 2018-2033 41

Table 10: Hydrocephalus Valves Market, Australia, Revenue ($m), USD Constant, 2018-2033 43

Table 11: Hydrocephalus Shunts Market, Australia, Volume (Units), 2018-2033 45

Table 12: Hydrocephalus Catheters Market, Australia, Volume (Units), 2018-2033 47

Table 13: Hydrocephalus Valves Market, Australia, Volume (Units), 2018-2033 49

Table 14: Hydrocephalus Shunts Market, Australia, Average Price ($), 2018-2033 50

Table 15: Hydrocephalus Shunts Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2023 51

Table 16: Hydrocephalus Shunts Market, Australia, Company Share by Revenue ($m), USD Constant, 2023 53

Table 17: Interventional Neuroradiology Market, Australia, Segment Contribution (%), 2023 56

Table 18: Interventional Neuroradiology Market, Australia, Revenue ($m), USD Constant, 2018-2033 58

Table 19: Neurovascular Accessory Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 60

Table 20: Neurovascular Coiling Assist Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 62

Table 21: Neurovascular Embolization Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 64

Table 22: Neurovascular Thrombectomy Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 66

Table 23: Interventional Neuroradiology Market, Australia, Volume (Units), 2018-2033 68

Table 24: Neurovascular Accessory Devices Market, Australia, Volume (Units), 2018-2033 70

Table 25: Neurovascular Coiling Assist Devices Market, Australia, Volume (Units), 2018-2033 72

Table 26: Neurovascular Embolization Devices Market, Australia, Volume (Units), 2018-2033 74

Table 27: Neurovascular Thrombectomy Devices Market, Australia, Volume (Units), 2018-2033 76

Table 28: Interventional Neuroradiology Market, Australia, Average Price ($), 2018-2033 77

Table 29: Interventional Neuroradiology Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2023 79

Table 30: Interventional Neuroradiology Market, Australia, Company Share by Revenue ($m), USD Constant, 2023 81

Table 31: Minimally Invasive Neurosurgery Market, Australia, Segment Contribution (%), 2023 84

Table 32: Minimally Invasive Neurosurgery Market, Australia, Revenue ($m), USD Constant, 2018-2033 86

Table 33: Minimally Invasive Neurosurgical Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 88

Table 34: Minimally Invasive Neurosurgery Market, Australia, Volume (Units), 2018-2033 90

Table 35: Minimally Invasive Neurosurgical Devices Market, Australia, Volume (Units), 2018-2033 92

Table 36: Minimally Invasive Neurosurgery Market, Australia, Average Price ($), 2018-2033 93

Table 37: Minimally Invasive Neurosurgery Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2023 94

Table 38: Minimally Invasive Neurosurgery Market, Australia, Company Share by Revenue ($m), USD Constant, 2023 96

Table 39: Neurological Diagnostic and Monitoring Equipment Market, Australia, Segment Contribution (%), 2023 99

Table 40: Neurological Diagnostic and Monitoring Equipment Market, Australia, Revenue ($m), USD Constant, 2018-2033 101

Table 41: Electrical Activity Testing Market, Australia, Revenue ($m), USD Constant, 2018-2033 103

Table 42: ICP Monitoring Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 105

Table 43: Neurological Diagnostic and Monitoring Equipment Market, Australia, Volume (Units), 2018-2033 107

Table 44: Electrical Activity Testing Market, Australia, Volume (Units), 2018-2033 109

Table 45: ICP Monitoring Devices Market, Australia, Volume (Units), 2018-2033 111

Table 46: Neurological Diagnostic and Monitoring Equipment Market, Australia, Average Price ($), 2018-2033 112

Table 47: Neurological Diagnostic and Monitoring Equipment Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2023 113

Table 48: Neurological Diagnostic and Monitoring Equipment Market, Australia, Company Share by Revenue ($m), USD Constant, 2023 115

Table 49: Neuromodulation Devices Market, Australia, Segment Contribution (%), 2023 118

Table 50: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 120

Table 51: Deep Brain Stimulators (DBS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 122

Table 52: Gastric Electric Stimulators (GES) Market, Australia, Revenue ($m), USD Constant, 2018-2033 124

Table 53: Peripheral Nerve Stimulators (PNS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 126

Table 54: Sacral Nerve Stimulators (SNS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 128

Table 55: Spinal Cord Stimulators (SCS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 130

Table 56: Vagus Nerve Stimulators (VNS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 132

Table 57: Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033 134

Table 58: Deep Brain Stimulators (DBS) Market, Australia, Volume (Units), 2018-2033 136

Table 59: Gastric Electric Stimulators (GES) Market, Australia, Volume (Units), 2018-2033 138

Table 60: Peripheral Nerve Stimulators (PNS) Market, Australia, Volume (Units), 2018-2033 140

Table 61: Sacral Nerve Stimulators (SNS) Market, Australia, Volume (Units), 2018-2033 142

Table 62: Spinal Cord Stimulators (SCS) Market, Australia, Volume (Units), 2018-2033 144

Table 63: Vagus Nerve Stimulators (VNS) Market, Australia, Volume (Units), 2018-2033 146

Table 64: Neuromodulation Devices Market, Australia, Average Price ($), 2018-2033 147

Table 65: Neuromodulation Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2023 150

Table 66: Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2023 152

Table 67: Neurosurgical Products Market, Australia, Segment Contribution (%), 2023 155

Table 68: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, 2018-2033 157

Table 69: Dura Substitutes Market, Australia, Revenue ($m), USD Constant, 2018-2033 159

Table 70: Neuroendoscopes Market, Australia, Revenue ($m), USD Constant, 2018-2033 161

Table 71: Neurosurgical Drills Market, Australia, Revenue ($m), USD Constant, 2018-2033 163

Table 72: Neurosurgical Products Market, Australia, Volume (Units), 2018-2033 165

Table 73: Dura Substitutes Market, Australia, Volume (Units), 2018-2033 167

Table 74: Neuroendoscopes Market, Australia, Volume (Units), 2018-2033 169

Table 75: Neurosurgical Drills Market, Australia, Volume (Units), 2018-2033 171

Table 76: Neurosurgical Products Market, Australia, Average Price ($), 2018-2033 172

Table 77: Neurosurgical Products Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2023 174

Table 78: Neurosurgical Products Market, Australia, Company Share by Revenue ($m), USD Constant, 2023 176

Table 79: Radiosurgery Systems Market, Australia, Segment Contribution (%), 2023 179

Table 80: Radiosurgery Systems Market, Australia, Revenue ($m), USD Constant, 2018-2033 181

Table 81: Radiosurgery Systems Market, Australia, Volume (Units), 2018-2033 183

Table 82: Radiosurgery Systems Market, Australia, Average Price ($), 2018-2033 184

Table 83: Radiosurgery Systems Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2023 185

Table 84: Radiosurgery Systems Market, Australia, Company Share by Revenue ($m), USD Constant, 2023 187

Table 85: Neurology Devices Market Pipeline Products 192

Table 86: Osteopore to Raise USD3.43 Million in First Tranche Private Placement of 4% Notes Due 2027 203

Table 87: Osteopore to Raise USD3.43 Million in Second Tranche Private Placement of 4% Notes Due 2027 205

Table 89: HitiQ to Raise USD1.07 Million in Private Placement of 12.5% Convertible Notes Due 2025 206

Table 90: Emyria to Raise USD0.12 Million in Private Placement of Shares 207

Table 91: Renerve Raises USD4.59 Million in Initial Public Offering (IPO) of Shares 208

Table 92: Orthocell to Raise USD11.3 Million in Private Placement of Shares 209

Table 93 DorsaVi to Raise USD0.36 Million in First Tranche Private Placement of Shares 210

Table 94: DorsaVi to Raise USD0.36 Million in Second Tranche Private Placement of Shares 211

Table 95: Compumedics Raises USD1.26 Million in Private Placement of Shares 212

Table 96: Dorsavi Raises USD0.03 Million in Private Placement of Shares 214

Table 97: Neurode Raises USD3.5 Million in Pre-Seed Funding 215

Table 98: Total Number of Primary Research Participants, Neurology Devices Market, by Country 230

Figures

Figure 1: Neurology Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 21

Figure 2: Neurology Devices Market, Australia, Revenue Mix ($m), 2023 23

Figure 3: Neurology Devices Market, Australia, Category Contribution (%), 2023 24

Figure 4: Neurology Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 26

Figure 5: Neurology Devices Market, Australia, Volume (Units), 2018-2033 28

Figure 6: Neurology Devices Market, Australia, Volume (Units), 2018-2033 30

Figure 7: Neurology Devices Market, Australia, Company Share (%) 2023 33

Figure 8: Hydrocephalus Shunts Market, Australia, Revenue Mix ($m), 2023 35

Figure 9: Hydrocephalus Shunts Market, Australia, Segment Contribution (%), 2023 36

Figure 10: Hydrocephalus Shunts Market, Australia, Revenue ($m), USD Constant, 2018-2033 38

Figure 11: Hydrocephalus Catheters Market, Australia, Revenue ($m), USD Constant, 2018-2033 40

Figure 12: Hydrocephalus Valves Market, Australia, Revenue ($m), USD Constant, 2018-2033 42

Figure 13: Hydrocephalus Shunts Market, Australia, Volume (Units), 2018-2033 44

Figure 14: Hydrocephalus Catheters Market, Australia, Volume (Units), 2018-2033 46

Figure 15: Hydrocephalus Valves Market, Australia, Volume (Units), 2018-2033 48

Figure 16: Hydrocephalus Shunts Market, Australia, Company Share (%) 2023 52

Figure 17: Interventional Neuroradiology Market, Australia, Revenue Mix ($m), 2023 54

Figure 18: Interventional Neuroradiology Market, Australia, Segment Contribution (%), 2023 55

Figure 19: Interventional Neuroradiology Market, Australia, Revenue ($m), USD Constant, 2018-2033 57

Figure 20: Neurovascular Accessory Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 59

Figure 21: Neurovascular Coiling Assist Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 61

Figure 22: Neurovascular Embolization Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 63

Figure 23: Neurovascular Thrombectomy Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 65

Figure 24: Interventional Neuroradiology Market, Australia, Volume (Units), 2018-2033 67

Figure 25: Neurovascular Accessory Devices Market, Australia, Volume (Units), 2018-2033 69

Figure 26: Neurovascular Coiling Assist Devices Market, Australia, Volume (Units), 2018-2033 71

Figure 27: Neurovascular Embolization Devices Market, Australia, Volume (Units), 2018-2033 73

Figure 28: Neurovascular Thrombectomy Devices Market, Australia, Volume (Units), 2018-2033 75

Figure 29: Interventional Neuroradiology Market, Australia, Company Share (%) 2023 80

Figure 30: Minimally Invasive Neurosurgery Market, Australia, Revenue Mix ($m), 2023 82

Figure 31: Minimally Invasive Neurosurgery Market, Australia, Segment Contribution (%), 2023 83

Figure 32: Minimally Invasive Neurosurgery Market, Australia, Revenue ($m), USD Constant, 2018-2033 85

Figure 33: Minimally Invasive Neurosurgical Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 87

Figure 34: Minimally Invasive Neurosurgery Market, Australia, Volume (Units), 2018-2033 89

Figure 35: Minimally Invasive Neurosurgical Devices Market, Australia, Volume (Units), 2018-2033 91

Figure 36: Minimally Invasive Neurosurgery Market, Australia, Company Share (%) 2023 95

Figure 37: Neurological Diagnostic and Monitoring Equipment Market, Australia, Revenue Mix ($m), 2023 97

Figure 38: Neurological Diagnostic and Monitoring Equipment Market, Australia, Segment Contribution (%), 2023 98

Figure 39: Neurological Diagnostic and Monitoring Equipment Market, Australia, Revenue ($m), USD Constant, 2018-2033 100

Figure 40: Electrical Activity Testing Market, Australia, Revenue ($m), USD Constant, 2018-2033 102

Figure 41: ICP Monitoring Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 104

Figure 42: Neurological Diagnostic and Monitoring Equipment Market, Australia, Volume (Units), 2018-2033 106

Figure 43: Electrical Activity Testing Market, Australia, Volume (Units), 2018-2033 108

Figure 44: ICP Monitoring Devices Market, Australia, Volume (Units), 2018-2033 110

Figure 45: Neurological Diagnostic and Monitoring Equipment Market, Australia, Company Share (%) 2023 114

Figure 46: Neuromodulation Devices Market, Australia, Revenue Mix ($m), 2023 116

Figure 47: Neuromodulation Devices Market, Australia, Segment Contribution (%), 2023 117

Figure 48: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033 119

Figure 49: Deep Brain Stimulators (DBS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 121

Figure 50: Gastric Electric Stimulators (GES) Market, Australia, Revenue ($m), USD Constant, 2018-2033 123

Figure 51: Peripheral Nerve Stimulators (PNS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 125

Figure 52: Sacral Nerve Stimulators (SNS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 127

Figure 53: Spinal Cord Stimulators (SCS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 129

Figure 54: Vagus Nerve Stimulators (VNS) Market, Australia, Revenue ($m), USD Constant, 2018-2033 131

Figure 55: Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033 133

Figure 56: Deep Brain Stimulators (DBS) Market, Australia, Volume (Units), 2018-2033 135

Figure 57: Gastric Electric Stimulators (GES) Market, Australia, Volume (Units), 2018-2033 137

Figure 58: Peripheral Nerve Stimulators (PNS) Market, Australia, Volume (Units), 2018-2033 139

Figure 59: Sacral Nerve Stimulators (SNS) Market, Australia, Volume (Units), 2018-2033 141

Figure 60: Spinal Cord Stimulators (SCS) Market, Australia, Volume (Units), 2018-2033 143

Figure 61: Vagus Nerve Stimulators (VNS) Market, Australia, Volume (Units), 2018-2033 145

Figure 62: Neuromodulation Devices Market, Australia, Company Share (%) 2023 151

Figure 63: Neurosurgical Products Market, Australia, Revenue Mix ($m), 2023 153

Figure 64: Neurosurgical Products Market, Australia, Segment Contribution (%), 2023 154

Figure 65: Neurosurgical Products Market, Australia, Revenue ($m), USD Constant, 2018-2033 156

Figure 66: Dura Substitutes Market, Australia, Revenue ($m), USD Constant, 2018-2033 158

Figure 67: Neuroendoscopes Market, Australia, Revenue ($m), USD Constant, 2018-2033 160

Figure 68: Neurosurgical Drills Market, Australia, Revenue ($m), USD Constant, 2018-2033 162

Figure 69: Neurosurgical Products Market, Australia, Volume (Units), 2018-2033 164

Figure 70: Dura Substitutes Market, Australia, Volume (Units), 2018-2033 166

Figure 71: Neuroendoscopes Market, Australia, Volume (Units), 2018-2033 168

Figure 72: Neurosurgical Drills Market, Australia, Volume (Units), 2018-2033 170

Figure 73: Neurosurgical Products Market, Australia, Company Share (%) 2023 175

Figure 74: Radiosurgery Systems Market, Australia, Revenue Mix ($m), 2023 177

Figure 75: Radiosurgery Systems Market, Australia, Segment Contribution (%), 2023 178

Figure 76: Radiosurgery Systems Market, Australia, Revenue ($m), USD Constant, 2018-2033 180

Figure 77: Radiosurgery Systems Market, Australia, Volume (Units), 2018-2033 182

Figure 78: Radiosurgery Systems Market, Australia, Company Share (%) 2023 186

Australia Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports

Medical Devices

New

Adult Feeding Tubes and Formula Market Size by Segments, Share,…

Medical Devices

New

Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Body Contouring Devices Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Australia Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others in real time.

Access a live Australia Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Australia Neurology Devices Market Outlook to 2033: Interventional Neuroradiology, Radiosurgery Systems, Hydrocephalus Shunts and Others

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports